Skip to content
value.today

Sagent Holding Co.

🇺🇸 Schaumburg, Illinois, USAPharmaceuticalsFounded 2006

Formerly NHS PHARMACEUTICALS

Total raised
$46 M
3 rounds on record
Latest round
$6 M
Sep 2010
First round on record
May 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Sagent Holding Co.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2010$6 MNo. 3$2 to $10 million

Sagent Holding Co.: Raise no. 3, Sep 2010

Investors in this round

2 investors had bought by the notice of Sep 14, 2010: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Sagent Holding Co. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Cayman Islands

People named in the notice

  • Jeffrey Yordon · Executive Officer, Director
  • Ronald Pauli · Executive Officer
  • Anthony Krizman · Director
  • Chen Yu · Director
  • Frank Kung · Director
  • James Sperans · Director
  • Mark Qiu · Director
  • Robert Flanagan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series B-1 Preference Shares”

Signed by Ronald E. Pauli, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 14, 2010. Read the notice at the SEC.

equitySEC
Mar 2010$10 MNo. 2$2 to $10 million

Sagent Holding Co.: Raise no. 2, Mar 2010

Investors in this round

1 investor had bought by the notice of Apr 5, 2010: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Sagent Holding Co. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Cayman Islands

People named in the notice

  • Jeffrey Yordon · Executive Officer, Director
  • Ronald Pauli · Executive Officer
  • Chen Yu · Director
  • Frank Kung · Director
  • James Sperans · Director
  • Robert Flanagan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series B Preference Shares”

Signed by Ronald E. Pauli, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 5, 2010. Read the notice at the SEC.

equitySEC
May 2009$30 MNo. 1$10 to $50 million

Sagent Holding Co.: Raise no. 1, May 2009

Investors in this round

10 investors had bought by the notice of Jun 2, 2009: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Sagent Holding Co. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Cayman Islands

People named in the notice

  • Jeffrey Yordon · Executive Officer, Director
  • Ronald E. Pauli · Executive Officer
  • Chen Yu · Director
  • Frank Kung · Director
  • James Sperans · Director
  • Robert Flanagan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ronald E. Pauli, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 2, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Sagent Holding Co. chose not to state its revenue in its newest notice of a funding round (Sep 2010).

    SEC Form D · Sep 2010

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Sep 2010

That is all the official record says: Sagent Holding Co. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

4 named in official filings. Open an investor to see everything it has backed.

Investors in Sagent Holding Co.
InvestorKindAmountRoundRoleSource
China Harvest Fund II, LPFund or asset managernot statednot statedHeld Series B-1 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
China Renaissance Capital Investment II GPFund or asset managernot statednot statedHeld Series B-1 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
China Renaissance Capital Investment II, L.P.Fund or asset managernot statednot statedHeld Series B-1 preferred stock, 10% owner (Form 3, 2011)SEC Form 3
Key Gate Investments LtdFund or asset managernot statednot statedHeld Series B-1 preferred stock, 10% owner (Form 3, 2011)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sagent Holding Co.
NameRoleNamed in
Jeffrey YordonExecutive officerSep 2010
Ronald PauliExecutive officerSep 2010
Ronald E. PauliExecutive officerJun 2009
Anthony KrizmanDirectorSep 2010
Chen YuDirectorSep 2010
Frank KungDirectorSep 2010
James SperansDirectorSep 2010
Jeffrey YordonDirectorSep 2010
Mark QiuDirectorSep 2010
Robert FlanaganDirectorSep 2010